Welcome
The Cardio-CARE at Medizincampus Davos, Switzerland, is funded by the Kühne Foundation. With 13 million Swiss Francs, it enables the largest research program to date for genome decoding in German-speaking regions. The main aims of our project are to
- better understand the genetic basic of cardiovascular diseases,
- improve its diagnosis, and
- identify drug targets.
This multidisciplinary project benefits from the intensive collaboration between the Kühne Foundation, the University Medical Center Zurich (USZ), and the University Medical Center Hamburg-Eppendorf (UKE).
“In future, diseases will be better avoided and cured if we help the medical profession to better understand the occurrence of disease in each individual.”
─ Prof. Dr. h.c. Klaus-Michael Kühne ─
Everything about Cardio-CARE
- Experts in pre-processing of large-scale high-throughput genome sequences.
- Experts in data analysis of high-throughput genome sequences.
- Long-standing experience in machine learning and artificial intelligence.
- Support planning, conduct and analysis of trials focusing on cardiovascular diseases and personalized medicine.
- Support planning, conduct and analysis of trials focusing on medical devices, such as telemonitoring.
- Perform friendly customer-oriented biostatistical and bioinformatical consulting.
News
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Sit amet aliquam id diam. Interdum posuere lorem ipsum dolor sit amet consectetur adipiscing. Vitae suscipit tellus mauris a diam maecenas sed enim. Purus non enim praesent elementum facilisis leo. Egestas erat imperdiet sed euismod nisi porta lorem. Sapien pellentesque habitant morbi tristique senectus et netus.
Kühne-Foundation Annual Report 2020
“Key priority of the Kühne Foundation is the support for training, further education as well as research and science in the area of logistics. This
A new patent submitted
Professor Andreas Ziegler, as the co-inventor, submitted the computing device for estimating the probability of myocardial infarction to European Patent Office. This work is in
